Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,194	1,286	1,291	614	2,966	1,750
Market Cap Growth	52.40%	-0.41%	110.30%	-79.30%	69.42%	-20.79%
Enterprise Value	961	1,025	1,047	246	2,688	1,367
Last Close Price	9.07	8.98	8.99	4.32	22.87	13.83
PE Ratio	33.23	223.53	-	-	-	-
Forward PE	14.05	24.06	-	-	-	-
PS Ratio	5.20	5.47	7.36	4.58	65.03	34.93
PB Ratio	3.57	3.41	3.42	1.51	6.19	4.29
P/TBV Ratio	3.46	3.45	3.46	1.54	6.30	4.39
P/FCF Ratio	18.68	29.15	-	-	-	-
P/OCF Ratio	18.60	28.97	-	-	-	-
EV/Sales Ratio	3.89	4.36	5.97	1.84	58.94	27.27
EV/EBITDA Ratio	15.52	32.08	-	-	-	-
EV/EBIT Ratio	22.63	81.91	-	-	-	-
EV/FCF Ratio	15.02	23.25	-	-	-	-
Debt / Equity Ratio	0.22	0.21	0.26	0.02	0.02	0.02
Debt / EBITDA Ratio	1.24	2.42	-	-	-	-
Debt / FCF Ratio	1.22	1.80	-	-	-	-
Asset Turnover	0.48	0.43	0.35	0.26	0.09	0.13
Inventory Turnover	1.16	1.24	1.98	2.30	3.14	-
Quick Ratio	5.16	4.05	4.86	8.76	11.84	12.45
Current Ratio	5.93	4.57	5.50	9.60	12.63	13.11
Return on Equity (ROE)	11.23%	1.52%	-19.92%	-24.46%	-40.81%	-29.07%
Return on Assets (ROA)	5.20%	1.42%	-10.53%	-13.74%	-22.43%	-16.54%
Return on Capital (ROIC)	6.06%	1.68%	-12.06%	-15.46%	-24.99%	-18.24%
Return on Capital Employed (ROCE)	9.70%	2.80%	-	-	-	-
Earnings Yield	3.33%	0.45%	-6.04%	-17.62%	-6.10%	-5.87%
FCF Yield	5.35%	3.43%	-2.65%	-13.00%	-5.33%	-4.32%
Buyback Yield / Dilution	-1.68%	-2.07%	-0.93%	-9.70%	-9.20%	-27.36%

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q